The Russian vaccine produced at the Serbian enterprise “Torlak” has been tested at the Institute of Epidemiology and Microbiology named after Gamaleya and approved for use.
According to Sputnik Serbia, the Russian National Institute of Epidemiology and Microbiology. Gamalei has confirmed the quality of the vaccine produced at Torlak and approved the production of the Sputnik V vaccine against the corona virus in the future at this Serbian institute. Today in Moscow at a meeting of the Minister in the Government of Serbia and the President of the Mixed Committee for Cooperation with Russia Nenad Popovic and Director of the Institute. Gamaleya Alexander Gintsbur, it was announced that Serbia will be the first country in Europe to produce the Sputnik V vaccine.
“Institute named after Gamalei confirmed that the vaccines produced in Torlak meet the established quality standards. Today we received this confirmation from our Russian partners, and we received approval to continue production, – said Popovic, noting that this is great news for Serbia, – Today we have the most powerful “weapon” with which we will protect the health of our citizens “.
He also noted that in the next two weeks a significant amount of the necessary substances will arrive from Russia to Serbia for the production of both components of the Sputnik V vaccine.
“Very soon, Serbia will have enough vaccines to fully cover its domestic needs, and we will discuss with Serbian President Aleksandar Vucic the possibility of sending the vaccine outside Serbia in order to help our partners in the region and Europe in the fight against coronavirus,” the Serbian noted. minister.
Popovic thanked President Vucic, the Serbian government, the leadership and staff of the Torlak Institute for the support of this important project for Serbia, the President of the country Vucic, as well as all those who believed that this moment would come and that Serbia, with the help of Russia, would establish the production of a vaccine against coronavirus on its territory.